Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Dec
23
2022
 OECD Accepting Comment on Draft Study Report on Applicability of the key event based TG 442D for in vitro skin sensitisation testing of nano-materials Bergeson & Campbell, P.C.
Dec
22
2022
 Omnibus Bill for Fiscal Year 2023 (H.R. 2617) – Cosmetics Summary Keller and Heckman LLP
Dec
22
2022
 Consumer Reports Evaluates Heavy Metals in Chocolate Keller and Heckman LLP
Dec
22
2022
 Heinz PFAS Consumer Fraud Lawsuit Continues 2022 Trend CMBG3 Law
Dec
21
2022
 PTO Expands the Scope of the Immunotherapy Pilot Program
Dec
21
2022
 ANSES Applies Methodology to Assess Risks of Nanomaterials in Food to Titanium Dioxide Bergeson & Campbell, P.C.
Dec
21
2022
 FTC Revises Longstanding “Dietary Supplement Guide” to Cover all Health Products Hunton Andrews Kurth
Dec
21
2022
 FDA Issues Final Guidance on GRAS Panel Best Practices Keller and Heckman LLP
Dec
20
2022
 Comment Period for “Healthy” Regulations Extended; But Consumer Class Actions Targeting “Health Halos” May Continue Sheppard, Mullin, Richter & Hampton LLP
Dec
20
2022
 OSTP Publishes RFIs on Coordinated Framework for the Regulation of Biotechnology and National Biotechnology and Biomanufacturing Initiative Bergeson & Campbell, P.C.
Dec
20
2022
 Mississippi Department of Health Releases Proposed Modifications to Medical Cannabis Regulations Bradley Arant Boult Cummings LLP
Dec
20
2022
 California Legislative Update Part II: Upcoming Changes for Health Facilities Mintz
Dec
20
2022
 Office of Science and Technology Policy Requests Public Input on Biotechnology Regulation Keller and Heckman LLP
Dec
19
2022
 340B Hospital Reimbursement Update – Underpayments and the Need to Act Now Polsinelli PC
Dec
19
2022
 Proposed Changes to the Canadian Feed Ingredients Table Keller and Heckman LLP
Dec
16
2022
 FTC Starts Long-Awaited Green Guides Review Keller and Heckman LLP
Dec
16
2022
 EUON Announces Results of Desk Study on (Bio)degradation, Persistence, and SbD of Nanomaterials Bergeson & Campbell, P.C.
Dec
15
2022
 Psychedelic Drugs – Easing the Regulatory Hurdles for Development Foley & Lardner LLP
Dec
15
2022
 Economically Motivated Adulteration in Honey Keller and Heckman LLP
Dec
15
2022
 China Announces New Management Measures for Food-Related Products Keller and Heckman LLP
Dec
14
2022
 FDA Published Food Safety Culture Literature Review Keller and Heckman LLP
Dec
13
2022
 California’s Newly Adopted “Safe Harbor” Warning Label for Acrylamide In Foods Turns Up the Heat In Ongoing First Amendment Challenge to Proposition 65 Sheppard, Mullin, Richter & Hampton LLP
Dec
13
2022
 FDA Letter States that β-Nicotinamide Mononucleotide is Not Lawful Dietary Supplement Keller and Heckman LLP
Dec
13
2022
 Warning Sign? A New Round of FDA Warning Letters Over CBD Consumer Confusion May Signal a Shift in Government Enforcement Bradley Arant Boult Cummings LLP
Dec
12
2022
 American Hospital Association Urges DEA to Issue Special Registration for Telemedicine Controlled Substances Foley & Lardner LLP
Dec
12
2022
 “Cold-Pressed Juice” Lawsuit Permanently Dismissed Keller and Heckman LLP
Dec
10
2022
 HHS Goes Back to The Drawing Board on the 340B ADR Process McDermott Will & Emery
Dec
8
2022
 FDA Releases Traceability Final Rule K&L Gates LLP
Displaying 2605 - 2632 of 12182
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters